1007352-17-1Relevant academic research and scientific papers
2-Substituted N-aryl piperazines as novel triple reuptake inhibitors for the treatment of depression
Carter, David S.,Cai, Hai-Ying,Lee, Eun Kyung,Iyer, Pravin S.,Lucas, Matthew C.,Roetz, Ralf,Schoenfeld, Ryan C.,Weikert, Robert J.
experimental part, p. 3941 - 3945 (2010/09/03)
Recently a class of compounds known as triple reuptake inhibitors has emerged as a new strategy for the treatment of depression. These compounds work by simultaneously inhibiting the synaptic reuptake of serotonin, norepinephrine and dopamine. In this Let
Arylpiperazine derivatives and uses thereof
-
Page/Page column 24-25, (2008/06/13)
Compounds of the formula: or pharmaceutically acceptable salts thereof, wherein m, n, X, Y, Z, Ar, R1, R2, R3, R4, R5, R6 and R7 are defined herein. Also provided are pharmaceuti
